Armistice Capital’s Exelixis EXEL Stock Holding History

Armistice Capital’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,270,000	Closed	-$7.16M	–	37
2015 Q4	$7.16M	Buy	+1,270,000	New	+$7.11M	2.56%	19

Other funds holding EXEL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Armistice Capital's EXEL Position: Q1 2016 in Review

Armistice Capital sold out of Exelixis (EXEL) in Q1 2016, closing a stake of 1,270,000 shares — an estimated $7.16M sold.

Armistice Capital first reported a position in EXEL in Q4 2015 and held it in 1 quarter. The position peaked at $7.16M in Q4 2015. 144 funds tracked by Wall St. Rank hold EXEL as of Q1 2016.

Armistice Capital reported no remaining Exelixis position as of Q1 2016 after selling out during the quarter.
Armistice Capital sold 1,270,000 Exelixis shares in Q1 2016, an estimated $7.16M.
Armistice Capital first reported a position in Exelixis in Q4 2015 and held it in 1 quarter.
Armistice Capital's Exelixis position peaked at $7.16M in Q4 2015.
144 funds tracked by Wall St. Rank held Exelixis as of Q1 2016.

Based on Armistice Capital's 13F filing for Q1 2016, filed 16 May 2016.